West Pharmaceutical Services Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2020
Total Assets: $2.79B
Liabilities Breakdown FY2020
Total Liabilities: $939.3M
Asset Breakdown
Total Assets: $2.79B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $615.5M | 22.0% |
| Accounts Receivable | $385.3M | 13.8% |
| Inventory | $321.3M | 11.5% |
| Property, Plant & Equipment | $943.2M | 33.8% |
| Goodwill | $111.1M | 4.0% |
| Intangible Assets | $30.5M | 1.1% |
| Other Assets | $386.9M | 13.8% |
Liabilities Breakdown
Total Liabilities: $939.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $213.1M | 22.7% |
| Long-Term Debt | $252.9M | 26.9% |
| Other Liabilities | $473.3M | 50.4% |